Cytek Biosciences, Inc. (CTKB)

Cytek Biosciences Revenue

In the year 2023, Cytek Biosciences had annual revenue of $193.02M with 17.67% growth. Revenue in the quarter ending December 31, 2023 was $58.23M with 20.48% year-over-year growth.

• Revenue (ttm): $193.02M
• Revenue Growth: +17.67%
• P/S Ratio: 4.33
• Revenue / Employee: $285,525
• Employees: 676
• Market Cap: 836.15M USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	193.02M	28.98M	17.67%
Dec 31, 2022	164.04M	36.09M	28.20%
Dec 31, 2021	127.95M	35.11M	37.82%
Dec 31, 2020	92.84M	34.96M	60.39%
Dec 31, 2019	57.88M	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.